Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Olsen

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Journal of Molecular Graphics & Modelling|July 8, 2014
Trends in predicted chemoselectivity of cytochrome P450 oxidation: B3LYP barrier heights for epoxidation and hydroxylation reactionsPatrik Rydberg, Richard Lonsdale, Jeremy N Harvey, et al.
Journal of Computer-Aided Molecular Design|November 26, 2004
Docking and scoring of metallo-beta-lactamases inhibitorsLars Olsen, Ingrid Pettersson, Lars Hemmingsen, et al.
The Journal of Biological Chemistry|November 20, 2008
Saccharomyces cerevisiae linker histone Hho1p functionally interacts with core histone H4 and negatively regulates the establishment of transcriptionally silent chromatinQun Yu, Holly Kuzmiak, Yanfei Zou, et al.
Journal of Computational Chemistry|September 5, 2002
Binding of D- and L-captopril inhibitors to metallo-beta-lactamase studied by polarizable molecular mechanics and quantum mechanicsJens Antony, Nohad Gresh, Lars Olsen, et al.
Carbohydrate Research|March 11, 2004
Evaluation of carbohydrate molecular mechanical force fields by quantum mechanical calculationsLars Hemmingsen, Daniel E Madsen, Anders L Esbensen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 24, 2010
Computational prediction of binding affinity for CYP1A2-ligand complexes using empirical free energy calculationsPoongavanam Vasanthanathan, Lars Olsen, Flemming Steen Jørgensen, et al.
Bioorganic & Medicinal Chemistry|December 28, 2005
New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore designLars Olsen, Sandra Jost, Hans-Werner Adolph, et al.
BMC Medical Genomics|December 19, 2014
Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomasLars Olsen, Benito Campos, Ole Winther, et al.
Journal of Chemical Theory and Computation|December 2, 2015
Transition-State Docking of Flunitrazepam and Progesterone in Cytochrome P450Patrik Rydberg, Sine Myrup Hansen, Jacob Kongsted, et al.
Journal of Chemical Information and Modeling|April 25, 2012
RS-Predictor models augmented with SMARTCyp reactivities: robust metabolic regioselectivity predictions for nine CYP isozymesJed Zaretzki, Patrik Rydberg, Charles Bergeron, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Journal of Molecular Graphics & Modelling|July 8, 2014
Trends in predicted chemoselectivity of cytochrome P450 oxidation: B3LYP barrier heights for epoxidation and hydroxylation reactionsPatrik Rydberg, Richard Lonsdale, Jeremy N Harvey, et al.
Journal of Computer-Aided Molecular Design|November 26, 2004
Docking and scoring of metallo-beta-lactamases inhibitorsLars Olsen, Ingrid Pettersson, Lars Hemmingsen, et al.
The Journal of Biological Chemistry|November 20, 2008
Saccharomyces cerevisiae linker histone Hho1p functionally interacts with core histone H4 and negatively regulates the establishment of transcriptionally silent chromatinQun Yu, Holly Kuzmiak, Yanfei Zou, et al.
Journal of Computational Chemistry|September 5, 2002
Binding of D- and L-captopril inhibitors to metallo-beta-lactamase studied by polarizable molecular mechanics and quantum mechanicsJens Antony, Nohad Gresh, Lars Olsen, et al.
Carbohydrate Research|March 11, 2004
Evaluation of carbohydrate molecular mechanical force fields by quantum mechanical calculationsLars Hemmingsen, Daniel E Madsen, Anders L Esbensen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 24, 2010
Computational prediction of binding affinity for CYP1A2-ligand complexes using empirical free energy calculationsPoongavanam Vasanthanathan, Lars Olsen, Flemming Steen Jørgensen, et al.
Bioorganic & Medicinal Chemistry|December 28, 2005
New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore designLars Olsen, Sandra Jost, Hans-Werner Adolph, et al.
BMC Medical Genomics|December 19, 2014
Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomasLars Olsen, Benito Campos, Ole Winther, et al.
Journal of Chemical Theory and Computation|December 2, 2015
Transition-State Docking of Flunitrazepam and Progesterone in Cytochrome P450Patrik Rydberg, Sine Myrup Hansen, Jacob Kongsted, et al.
Journal of Chemical Information and Modeling|April 25, 2012
RS-Predictor models augmented with SMARTCyp reactivities: robust metabolic regioselectivity predictions for nine CYP isozymesJed Zaretzki, Patrik Rydberg, Charles Bergeron, et al.
Pageof 10